EMA Joins Review of Testosterone Drug-Heart Attack Link

Drug Industry Daily
A A
The European Medicines Agency is looking into potential heart risks linked to testosterone-containing drugs after an EU member state regulator raised safety concerns.

To View This Article:

Login

Subscribe To Drug Industry Daily